000 | 01050 a2200313 4500 | ||
---|---|---|---|
005 | 20250511192939.0 | ||
264 | 0 | _c19920609 | |
008 | 199206s 0 0 eng d | ||
022 | _a0266-9536 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSpiller, D G | |
245 | 0 | 0 |
_aThe uptake kinetics of chimeric oligodeoxynucleotide analogues in human leukaemia MOLT-4 cells. _h[electronic resource] |
260 |
_bAnti-cancer drug design _cApr 1992 |
||
300 |
_a115-29 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAmino Acid Sequence |
650 | 0 | 4 | _aBase Sequence |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 | _aGenes, myc |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aLeukemia-Lymphoma, Adult T-Cell _xmetabolism |
650 | 0 | 4 | _aMicroscopy, Fluorescence |
650 | 0 | 4 | _aMolecular Sequence Data |
650 | 0 | 4 |
_aOligodeoxyribonucleotides _xgenetics |
650 | 0 | 4 | _aTumor Cells, Cultured |
700 | 1 | _aTidd, D M | |
773 | 0 |
_tAnti-cancer drug design _gvol. 7 _gno. 2 _gp. 115-29 |
|
999 |
_c1582368 _d1582368 |